Press releases
12th Aug 2024
First UK commercial sales of the Genedrive® CYP2C19 ID Kit
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...
6th Aug 2024
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that its...
31st Jul 2024
NICE recommends the Genedrive® CYP2C19 ID Kit in final guidance
genedrive plc (AIM: GDR), the point-of-care pharmacogenetic testing company, is pleased to anno...